[1]
CavalcanteG.V., VianaT.L., AraújoV. dos S. and NascimentoL. de C.S. do 2025. Pharmacovigilance and adverse events associated with losartan potassium. Electronic Journal Collection Health. 25, (Apr. 2025), e19385. DOI:https://doi.org/10.25248/reas.e19385.2025.